|
INSIG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3999999999913E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46049999998998E-05 |
| Normal-vs-Stage2 |
2.86230000001719E-06 |
| Normal-vs-Stage3 |
2.162000E-04 |
| Normal-vs-Stage4 |
8.605400E-04 |
| Stage1-vs-Stage2 |
1.357400E-01 |
| Stage1-vs-Stage3 |
5.481600E-01 |
| Stage1-vs-Stage4 |
4.425800E-01 |
| Stage2-vs-Stage3 |
1.014630E-01 |
| Stage2-vs-Stage4 |
8.082300E-02 |
| Stage3-vs-Stage4 |
8.013600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.36689999999684E-05 |
| Normal-vs-AfricanAmerican |
3.020900E-03 |
| Normal-vs-Asian |
2.166800E-04 |
| Caucasian-vs-AfricanAmerican |
8.693400E-01 |
| Caucasian-vs-Asian |
8.956600E-01 |
| AfricanAmerican-vs-Asian |
9.338000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.60929999999793E-05 |
| Normal-vs-Female |
2.01069999999914E-05 |
| Male-vs-Female |
5.490200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.028140E-04 |
| Normal-vs-Age(41-60Yrs) |
1.53948999999098E-05 |
| Normal-vs-Age(61-80Yrs) |
3.9772000000049E-05 |
| Normal-vs-Age(81-100Yrs) |
9.855000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.838000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.490600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.131000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.682200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.643050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.795590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.715600E-01 |
| Classical-VS-Follicular |
4.641800E-04 |
| Classical-VS-Other |
1.633390E-01 |
| Classical-VS-Normal |
2.449100E-04 |
| Tall-VS-Follicular |
5.812400E-02 |
| Tall-VS-Other |
2.324200E-01 |
| Tall-VS-Normal |
1.178730E-03 |
| Follicular-VS-Other |
7.911200E-01 |
| Follicular-VS-Normal |
2.61439999982294E-07 |
| Other-VS-Normal |
1.808050E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.50889999994686E-06 |
| Normal-vs-N1 |
1.79621999999435E-05 |
| N0-vs-N1 |
9.899400E-01 |
|
|
